Approval · Notice of Compliance 5398 · 1994
ABITREXATE: Notice of Compliance 5398
Issued May 11, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5398
- Date
- May 11, 1994
- Company
- Abic LimitedNetanya, Israel
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antimetabolite
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ABITREXATE | 02089920 | — |
Medicinal ingredients
- METHOTREXATE 25 MG per ML